检索结果 - Kristian Reich
- Showing 1 - 20 results of 125
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease... 由 Kristian Reich, Rotraut Mößner, Christine Neumann, Inke R. König, Götz Westphal, Andreas Ziegler
出版 2002Artigo -
14
Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) 由 Andrew Blauvelt, Melinda Gooderham, Lars Iversen, Susan Ball, Lu Zhang, Noah Agada, Kristian Reich
出版 2017Artigo -
15
-
16
-
17
-
18
-
19
Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalizati... 由 Kristian Reich, Volker Blaschke, Constance Maurer, Undine Lippert, Christine Neumann, Claus Garbe, Peter Middel, Götz Westphal
出版 2001Artigo -
20
Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in Psoriasis 由 Kristian Reich, Sabine Zipprich, Thomas Fuchs, Christine Neumann, Götz Westphal, Thomas Schulz, Michael Müller, Ernst Hallier
出版 1999Artigo
相关主题
Medicine
Dermatology
Psoriasis
Internal medicine
Psoriatic arthritis
Pathology
Alternative medicine
Placebo
Randomized controlled trial
Secukinumab
Adverse effect
Psoriasis Area and Severity Index
Disease
Immunology
Clinical trial
Surgery
Gastroenterology
Plaque psoriasis
Tumor necrosis factor alpha
Dermatology Life Quality Index
Atopic dermatitis
Biology
Ixekizumab
Physics
Adalimumab
Nursing
Quality of life (healthcare)
Cytokine
Clinical endpoint
Etanercept